Unlocking IPO Success: MBX Biosciences’ Journey to Financial Reporting Excellence
In preparation for public life, MBX Biosciences recognized that relying on tools such as Excel, Word, and PowerPoint for financial reporting limited their controls, while increasing opportunities for potential risks such as data accuracy, version management, and security. In order to enhance reporting and compliance, they needed a solution that could streamline the process, while also complementing their Oracle NetSuite environment.
With ActiveDisclosure, MBX Biosciences was able to supplement their NetSuite environment with Microsoft compatible software, enabling a successful IPO followed by timely, efficient financial reporting and SEC filing. Post-IPO, MBX Biosciences enhanced their financial reporting with DFIN’s automation capabilities—freeing their team from tedious formatting tasks and allowing them to focus on what truly drives business growth.
Read the Full Story